Form D · Pharmaceuticals
Bionpharma Inc.
Princeton, NJ · CIK 0001624663
Offering snapshot reported Dec 15, 2015 · SEC filing
- Reported sold
- $6.5M Offering amount: $6.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 15, 2015 | Initial | $6,500,000 | No comparison | 1 | SEC filing |
| May 27, 2015 | Amendment | $30,668,000 | $668,000vs Feb 4, 2015 | 10 | SEC filing |
| Feb 4, 2015 | Amendment | $30,000,000 | $8,725,000vs Nov 13, 2014 | 3 | SEC filing |
| Nov 13, 2014 | Initial | $21,275,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-253121
Common Stock
Source: Form D, filed Dec 15, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carol S. Ben Maimon | Director |
| James Gale | Director |
| David W. Goodman | Director |
| Venkatachalam Krishnan | Director, Executive |
| Gaurav Mehrotra | Executive |
| Lavesh Samtani | Executive |
| Richard Van Duyne | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
600 Alexander Road Suite 2 4 B
Princeton, NJ, 08540
Princeton, NJ, 08540